LivaNova to Announce Third-Quarter 2024 Results
LivaNova PLC (Nasdaq: LIVN), a leading medical technology company, has announced it will host a conference call to discuss its third-quarter 2024 results on Wednesday, October 30, 2024 at 12 p.m. London time (8 a.m. Eastern Time). The company will release its Q3 2024 results before the call. Investors and interested parties can access a live audiocast of the call at www.livanova.com/events.
To join the conference call by telephone, participants can dial +1 833 470 1428 from within the U.S. or +1 929 526 1599 from outside the U.S. The access code for the call is 881946. A replay of the call will be available on the LivaNova website for 90 days following the event.
LivaNova PLC (Nasdaq: LIVN), un'azienda leader nel settore della tecnologia medica, ha annunciato che ospiterà una conferenza telefonica per discutere i suoi risultati del terzo trimestre 2024 mercoledì, 30 ottobre 2024 alle 12:00 ora di Londra (8:00 ora dell'Est). L'azienda rilascerà i risultati del Q3 2024 prima della chiamata. Gli investitori e le parti interessate possono accedere a un audiocast dal vivo della chiamata su www.livanova.com/events.
Per partecipare alla conferenza telefonica, i partecipanti possono comporre +1 833 470 1428 dall'interno degli Stati Uniti o +1 929 526 1599 dall'estero. Il codice di accesso per la chiamata è 881946. Una registrazione della chiamata sarà disponibile sul sito web di LivaNova per 90 giorni dopo l'evento.
LivaNova PLC (Nasdaq: LIVN), una empresa líder en tecnología médica, ha anunciado que llevará a cabo una conferencia telefónica para discutir sus resultados del tercer trimestre de 2024 el miércoles, 30 de octubre de 2024 a las 12 p.m. hora de Londres (8 a.m. hora del Este). La empresa publicará sus resultados del Q3 2024 antes de la llamada. Los inversores y partes interesadas pueden acceder a una transmisión de audio en vivo de la llamada en www.livanova.com/events.
Para unirse a la conferencia telefónica, los participantes pueden marcar +1 833 470 1428 desde dentro de los EE. UU. o +1 929 526 1599 desde fuera de los EE. UU. El código de acceso para la llamada es 881946. Una reproducción de la llamada estará disponible en el sitio web de LivaNova durante 90 días después del evento.
LivaNova PLC (Nasdaq: LIVN)는 선도적인 의료 기술 회사로, 2024년 3분기 실적 발표를 위해 2024년 10월 30일 수요일 런던 시간으로 오후 12시(동부 표준시 기준 오전 8시)에 전화 회의를 개최할 것이라고 발표했습니다. 회의 전에 Q3 2024 실적이 공개될 예정입니다. 투자자 및 관계자는 www.livanova.com/events에서 회의의 실시간 오디오 방송에 접근할 수 있습니다.
전화로 회의에 참여하려면 참가자는 미국 내에서는 +1 833 470 1428으로, 미국 외에서는 +1 929 526 1599으로 전화해야 합니다. 회의 접근 코드는 881946입니다. 회의의 재생 기록은 행사 후 90일 동안 LivaNova 웹사이트에서 제공됩니다.
LivaNova PLC (Nasdaq: LIVN), une entreprise de technologie médicale de premier plan, a annoncé qu'elle organisera une conférence téléphonique pour discuter de ses résultats du troisième trimestre 2024 le mercredi 30 octobre 2024 à 12 heures, heure de Londres (8 heures, heure de l'Est). L'entreprise publiera ses résultats du T3 2024 avant l'appel. Les investisseurs et les parties intéressées peuvent accéder à un audiocast en direct de l'appel sur www.livanova.com/events.
Pour rejoindre la conférence par téléphone, les participants peuvent composer +1 833 470 1428 depuis les États-Unis ou +1 929 526 1599 depuis l'étranger. Le code d'accès pour l'appel est 881946. Un enregistrement de l'appel sera disponible sur le site Web de LivaNova pendant 90 jours suivant l'événement.
LivaNova PLC (Nasdaq: LIVN), ein führendes Unternehmen in der Medizintechnologie, hat angekündigt, eine Telefonkonferenz abzuhalten, um über seine Ergebnisse des dritten Quartals 2024 zu diskutieren. Dies wird am Mittwoch, den 30. Oktober 2024 um 12 Uhr Londoner Zeit (8 Uhr Eastern Time) stattfinden. Das Unternehmen wird die Ergebnisse für Q3 2024 vor der Konferenz veröffentlichen. Investoren und Interessierten steht ein Live-Audiocast der Konferenz unter www.livanova.com/events zur Verfügung.
Um an der Telefonkonferenz teilzunehmen, können die Teilnehmer innerhalb der USA +1 833 470 1428 oder außerhalb der USA +1 929 526 1599 wählen. Der Zugangscode für die Konferenz lautet 881946. Eine Aufzeichnung der Konferenz wird 90 Tage nach der Veranstaltung auf der LivaNova-Website verfügbar sein.
- None.
- None.
A live audiocast will be accessible at www.livanova.com/events. Listeners should log on approximately 10 minutes in advance to ensure proper setup to receive the audiocast. To listen to the conference call by telephone, dial +1 833 470 1428 (if dialing from within the
About LivaNova
LivaNova PLC is a global medical technology company built on nearly five decades of experience and a relentless commitment to provide hope for patients and their families through medical technologies, delivering life-changing solutions in select neurological and cardiac conditions. Headquartered in
Safe Harbor Statement
This news release contains “forward-looking statements” concerning the Company’s goals, beliefs, expectations, strategies, objectives, plans, underlying assumptions, and other statements that are not necessarily based on historical facts. These statements include, but are not limited to, statements regarding the next Company conference call. Actual events may differ materially from those indicated in our forward-looking statements as a result of various factors, including those factors set forth in Item 1A of the Company’s most recent Annual Report on Form 10-K, as supplemented by any risk factors contained in Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. LivaNova undertakes no obligation to update the information contained in this press release to reflect subsequently occurring events or circumstances.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240925920214/en/
LivaNova Investor Relations and Media Contacts
+1 281-895-2382
Briana Gotlin
Director, Investor Relations
InvestorRelations@livanova.com
Deanna Wilke
VP, Corporate Communications
Corporate.Communications@livanova.com
Source: LivaNova PLC
FAQ
When will LivaNova (LIVN) release its Q3 2024 financial results?
What time is LivaNova's (LIVN) Q3 2024 earnings conference call?
How can investors access LivaNova's (LIVN) Q3 2024 earnings call?